Global Rheumatoid Arthritis Therapeutics Market Research Report 2024

Report ID: 1898914 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rheumatoid Arthritis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Symptomatic Treatment
        1.2.3 Intermediate Corticosteroid Therapies
        1.2.4 Disease Modifying Antirheumatic Drug Therapies
    1.3 Market by Application
        1.3.1 Global Rheumatoid Arthritis Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Drug Stores
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rheumatoid Arthritis Therapeutics Market Perspective (2017-2028)
    2.2 Rheumatoid Arthritis Therapeutics Growth Trends by Region
        2.2.1 Rheumatoid Arthritis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rheumatoid Arthritis Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Rheumatoid Arthritis Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Rheumatoid Arthritis Therapeutics Market Dynamics
        2.3.1 Rheumatoid Arthritis Therapeutics Industry Trends
        2.3.2 Rheumatoid Arthritis Therapeutics Market Drivers
        2.3.3 Rheumatoid Arthritis Therapeutics Market Challenges
        2.3.4 Rheumatoid Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rheumatoid Arthritis Therapeutics Players by Revenue
        3.1.1 Global Top Rheumatoid Arthritis Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Rheumatoid Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rheumatoid Arthritis Therapeutics Revenue
    3.4 Global Rheumatoid Arthritis Therapeutics Market Concentration Ratio
        3.4.1 Global Rheumatoid Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Therapeutics Revenue in 2021
    3.5 Rheumatoid Arthritis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Rheumatoid Arthritis Therapeutics Product Solution and Service
    3.7 Date of Enter into Rheumatoid Arthritis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Therapeutics Breakdown Data by Type
    4.1 Global Rheumatoid Arthritis Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Rheumatoid Arthritis Therapeutics Breakdown Data by Application
    5.1 Global Rheumatoid Arthritis Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rheumatoid Arthritis Therapeutics Market Size (2017-2028)
    6.2 North America Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022)
    6.3 North America Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rheumatoid Arthritis Therapeutics Market Size (2017-2028)
    7.2 Europe Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rheumatoid Arthritis Therapeutics Market Size (2017-2028)
    9.2 Latin America Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Rheumatoid Arthritis Therapeutics Introduction
        11.1.4 Sanofi Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.1.5 Sanofi Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Rheumatoid Arthritis Therapeutics Introduction
        11.2.4 Pfizer Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Rheumatoid Arthritis Therapeutics Introduction
        11.3.4 Roche Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Rheumatoid Arthritis Therapeutics Introduction
        11.4.4 Johnson & Johnson Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 AbbVie
        11.5.1 AbbVie Company Detail
        11.5.2 AbbVie Business Overview
        11.5.3 AbbVie Rheumatoid Arthritis Therapeutics Introduction
        11.5.4 AbbVie Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.5.5 AbbVie Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Rheumatoid Arthritis Therapeutics Introduction
        11.6.4 Eli Lilly Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Detail
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Rheumatoid Arthritis Therapeutics Introduction
        11.7.4 Amgen Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.7.5 Amgen Recent Development
    11.8 Sobi
        11.8.1 Sobi Company Detail
        11.8.2 Sobi Business Overview
        11.8.3 Sobi Rheumatoid Arthritis Therapeutics Introduction
        11.8.4 Sobi Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.8.5 Sobi Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Detail
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Rheumatoid Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Symptomatic Treatment
    Table 3. Key Players of Intermediate Corticosteroid Therapies
    Table 4. Key Players of Disease Modifying Antirheumatic Drug Therapies
    Table 5. Global Rheumatoid Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Rheumatoid Arthritis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Rheumatoid Arthritis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Rheumatoid Arthritis Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Rheumatoid Arthritis Therapeutics Market Share by Region (2023-2028)
    Table 11. Rheumatoid Arthritis Therapeutics Market Trends
    Table 12. Rheumatoid Arthritis Therapeutics Market Drivers
    Table 13. Rheumatoid Arthritis Therapeutics Market Challenges
    Table 14. Rheumatoid Arthritis Therapeutics Market Restraints
    Table 15. Global Rheumatoid Arthritis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Rheumatoid Arthritis Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Rheumatoid Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Therapeutics as of 2021)
    Table 18. Ranking of Global Top Rheumatoid Arthritis Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Rheumatoid Arthritis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Rheumatoid Arthritis Therapeutics Product Solution and Service
    Table 22. Date of Enter into Rheumatoid Arthritis Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Rheumatoid Arthritis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Rheumatoid Arthritis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Sanofi Company Detail
    Table 43. Sanofi Business Overview
    Table 44. Sanofi Rheumatoid Arthritis Therapeutics Product
    Table 45. Sanofi Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Sanofi Recent Development
    Table 47. Pfizer Company Detail
    Table 48. Pfizer Business Overview
    Table 49. Pfizer Rheumatoid Arthritis Therapeutics Product
    Table 50. Pfizer Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Pfizer Recent Development
    Table 52. Roche Company Detail
    Table 53. Roche Business Overview
    Table 54. Roche Rheumatoid Arthritis Therapeutics Product
    Table 55. Roche Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Roche Recent Development
    Table 57. Johnson & Johnson Company Detail
    Table 58. Johnson & Johnson Business Overview
    Table 59. Johnson & Johnson Rheumatoid Arthritis Therapeutics Product
    Table 60. Johnson & Johnson Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Johnson & Johnson Recent Development
    Table 62. AbbVie Company Detail
    Table 63. AbbVie Business Overview
    Table 64. AbbVie Rheumatoid Arthritis Therapeutics Product
    Table 65. AbbVie Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. AbbVie Recent Development
    Table 67. Eli Lilly Company Detail
    Table 68. Eli Lilly Business Overview
    Table 69. Eli Lilly Rheumatoid Arthritis Therapeutics Product
    Table 70. Eli Lilly Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Eli Lilly Recent Development
    Table 72. Amgen Company Detail
    Table 73. Amgen Business Overview
    Table 74. Amgen Rheumatoid Arthritis Therapeutics Product
    Table 75. Amgen Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Amgen Recent Development
    Table 77. Sobi Company Detail
    Table 78. Sobi Business Overview
    Table 79. Sobi Rheumatoid Arthritis Therapeutics Product
    Table 80. Sobi Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Sobi Recent Development
    Table 82. Bristol-Myers Squibb Company Detail
    Table 83. Bristol-Myers Squibb Business Overview
    Table 84. Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Product
    Table 85. Bristol-Myers Squibb Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rheumatoid Arthritis Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Symptomatic Treatment Features
    Figure 3. Intermediate Corticosteroid Therapies Features
    Figure 4. Disease Modifying Antirheumatic Drug Therapies Features
    Figure 5. Global Rheumatoid Arthritis Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacy Case Studies
    Figure 7. Retail Pharmacy Case Studies
    Figure 8. Drug Stores Case Studies
    Figure 9. Rheumatoid Arthritis Therapeutics Report Years Considered
    Figure 10. Global Rheumatoid Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Rheumatoid Arthritis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Rheumatoid Arthritis Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Rheumatoid Arthritis Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Rheumatoid Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Therapeutics Revenue in 2021
    Figure 16. North America Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Rheumatoid Arthritis Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Rheumatoid Arthritis Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Rheumatoid Arthritis Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Rheumatoid Arthritis Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Rheumatoid Arthritis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Sanofi Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 47. Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 48. AbbVie Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 49. Eli Lilly Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 50. Amgen Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 51. Sobi Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Pfizer
Roche
Johnson & Johnson
AbbVie
Eli Lilly
Amgen
Sobi
Bristol-Myers Squibb
Frequently Asked Questions
Rheumatoid Arthritis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rheumatoid Arthritis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rheumatoid Arthritis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rheumatology Drugs

Rheumatology Drugs market is segmented by players, region (country), by Type and by Application.  ... Read More